These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3391204

  • 41. Comparative quantitation of menstrual blood loss with a d-norgestrel-releasing iud and a Nova-T-copper device.
    Nilsson CG.
    Contraception; 1977 Apr; 15(4):379-87. PubMed ID: 880815
    [No Abstract] [Full Text] [Related]

  • 42. Levonorgestrel-releasing intrauterine system: uses and controversies.
    Bahamondes L, Bahamondes MV, Monteiro I.
    Expert Rev Med Devices; 2008 Jul; 5(4):437-45. PubMed ID: 18573044
    [Abstract] [Full Text] [Related]

  • 43. Preliminary report on the use of danazol in the treatment of endometrial adenomatous hyperplasia.
    Terakawa N, Inoue M, Shimizu I, Ikegami H, Mizutani T, Sakata M, Tanizawa O, Matsumoto K.
    Cancer; 1988 Dec 15; 62(12):2618-21. PubMed ID: 3191463
    [Abstract] [Full Text] [Related]

  • 44. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials.
    Abu Hashim H, Ghayaty E, El Rakhawy M.
    Am J Obstet Gynecol; 2015 Oct 15; 213(4):469-78. PubMed ID: 25797236
    [Abstract] [Full Text] [Related]

  • 45. Successful twin pregnancy achieved by assisted reproductive technology in a patient with polycystic ovary syndrome with complex atypical endometrial hyperplasia treated with levonorgestrel-releasing intrauterine system.
    Ercan CM, Duru NK, Sakinci M, Alanbay I, Karasahin KE, Baser I.
    Gynecol Endocrinol; 2010 Feb 15; 26(2):125-8. PubMed ID: 20074021
    [Abstract] [Full Text] [Related]

  • 46. [Conservative organ-preserving measures in precancerous stages of endometrial cancer].
    Dallenbach-Hellweg G.
    Gynakologe; 1988 Dec 15; 21(4):302-7. PubMed ID: 2974824
    [No Abstract] [Full Text] [Related]

  • 47. Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study.
    Leone Roberti Maggiore U, Martinelli F, Dondi G, Bogani G, Chiappa V, Evangelista MT, Liberale V, Ditto A, Ferrero S, Raspagliesi F.
    J Gynecol Oncol; 2019 Jul 15; 30(4):e57. PubMed ID: 31074240
    [Abstract] [Full Text] [Related]

  • 48. [Current possibilities of examination and preservative treatment in endometrial hyperplasia].
    Kołodziejczak M, Knapp P, Kuźmicki M, Knapp P.
    Ginekol Pol; 2011 Jul 15; 82(7):514-9. PubMed ID: 21913429
    [Abstract] [Full Text] [Related]

  • 49. Progestin therapy in endometrial hyperplasia.
    Wentz WB.
    Gynecol Oncol; 1974 Aug 15; 2(2-3):362-7. PubMed ID: 4457410
    [No Abstract] [Full Text] [Related]

  • 50. Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential.
    Pronin SM, Novikova OV, Andreeva JY, Novikova EG.
    Int J Gynecol Cancer; 2015 Jul 15; 25(6):1010-4. PubMed ID: 25950126
    [Abstract] [Full Text] [Related]

  • 51. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG, Allonen H, Diaz J, Luukkainen T.
    Fertil Steril; 1983 Feb 15; 39(2):187-92. PubMed ID: 6401636
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The effects of clomiphene citrate on the endometrium.
    Wall JA, Franklin RR, Kaufman RH, Kaplan AL.
    Am J Obstet Gynecol; 1965 Nov 15; 93(6):842-9. PubMed ID: 5845216
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.
    Minig L, Franchi D, Boveri S, Casadio C, Bocciolone L, Sideri M.
    Ann Oncol; 2011 Mar 15; 22(3):643-649. PubMed ID: 20876910
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F, Guillebaud J.
    Drug Saf; 1996 Dec 15; 15(6):430-40. PubMed ID: 8968696
    [Abstract] [Full Text] [Related]

  • 59. Management of endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: single arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2006).
    Lee TS, Seong SJ, Kim JW, Ryu HS, Song ES, Nam BH.
    Jpn J Clin Oncol; 2011 Jun 15; 41(6):817-9. PubMed ID: 21478178
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.